v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total revenue $ 1,901 $ 0
Operating expenses:    
Cost of sales 1,076 0
Selling, general and administrative 44,960 11,113
Research and development 0 5,818
Total operating expenses 46,036 16,931
Loss from operations (44,135) (16,931)
Other income:    
Other income (expense) 3 (11)
Interest income 2,644 2,323
Total other income, net 2,647 2,312
Net loss (41,488) (14,619)
Other comprehensive loss:    
Unrealized loss on marketable securities (692) (73)
Comprehensive loss $ (42,180) $ (14,692)
Net loss per share - basic (in dollars per share) $ (1.32) $ (0.53)
Net loss per share - diluted (in dollars per share) $ (1.32) $ (0.53)
Weighted-average common shares outstanding, basic (in shares) 31,352,702 27,526,099
Weighted-average common shares outstanding, diluted (in shares) 31,352,702 27,526,099
Product sales, net    
Revenue:    
Total revenue $ 1,651 $ 0
License revenue    
Revenue:    
Total revenue $ 250 $ 0